Look for ingredients like avocado, olive oil and seaweed while shopping for face masks for winter to mask away the skin problems, say experts.
Do you frequently work in night shifts? Beware, you are more likely to develop Type 2 diabetes, a precursor to cardiovascular diseases, researchers have warned.
A new study published in journal BMJ Open has revealed that the habit of eating slowly could help to lose weight.
People born with heart defects may be at higher risk of developing dementia in adulthood, according to a new research.
An international team of scientists has successfully programmed nanorobots for the first time in mammals, that potentially shrinks tumours by cutting off their blood supply.
According to the new study report, playing a video game will tune down these external voices by controlling the part of the brain which triggers verbal hallucinations
Woman from Arizona has woke up with a British accent on one fine day, medical experts explain it differently
Scientists have developed a simple new DNA test that can detect 193 genetic diseases including anaemia, epilepsy and metabolic disorders in a newborn's genes.
Scientists have developed a new optical imaging system that uses red- and near-infrared light to predict response to chemotherapy by as early as two weeks.
These digital cancer samples in the virtual biobank are made up of high-resolution microscopy images in both 2D and 3D, plus important clinical and molecular information that may provide the foundation for virtual research into cancer.
In the midst of escalating tensions associated with yellow fever, more than 200 monkeys were killed by people in Rio de Janeiro.
A new study has found that the liquid used in e-cigarettes could cause damage to lungs over long-term abuse.
Using ultrasound and a blood test for high alpha-fetoprotein (AFP) levels together improves detection of early-stage liver cancer significantly.
Australian researchers said that they have developed the first virtual platform for storing 3D copies of human cancer tissues.
Combining an anti-angiogenesis agent with an immunotherapy agent, has shown promising anti-tumour activity in an early phase clinical trial in patients with advanced kidney cancer.